Carisma Therapeutics Inc. Annual Operating Income (Loss) in USD from 2012 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Carisma Therapeutics Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2012 to 2023.
  • Carisma Therapeutics Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$13.1M, a 41.2% increase year-over-year.
  • Carisma Therapeutics Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$66.8M, a 18.2% increase year-over-year.
  • Carisma Therapeutics Inc. annual Operating Income (Loss) for 2023 was -$88.7M, a 58% decline from 2022.
  • Carisma Therapeutics Inc. annual Operating Income (Loss) for 2022 was -$56.2M, a 557% decline from 2021.
  • Carisma Therapeutics Inc. annual Operating Income (Loss) for 2021 was -$8.55M, a 59.4% increase from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$88.7M -$32.6M -58% Jan 1, 2023 Dec 31, 2023 10-K 2024-04-01
2022 -$56.2M -$47.6M -557% Jan 1, 2022 Dec 31, 2022 10-K 2024-04-01
2021 -$8.55M +$12.5M +59.4% Jan 1, 2021 Dec 31, 2021 10-K 2023-02-28
2020 -$21.1M +$87.4M +80.6% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-28
2019 -$108M -$74M -214% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-28
2018 -$34.5M -$5.25M -17.9% Jan 1, 2018 Dec 31, 2018 10-K 2021-03-15
2017 -$29.3M -$32.1M -1121% Jan 1, 2017 Dec 31, 2017 10-K 2020-03-16
2016 $2.87M +$38.1M Jan 1, 2016 Dec 31, 2016 10-K 2019-03-01
2015 -$35.2M -$2.27M -6.88% Jan 1, 2015 Dec 31, 2015 10-K 2018-04-02
2014 -$32.9M -$16.5M -99.8% Jan 1, 2014 Dec 31, 2014 10-K 2017-03-24
2013 -$16.5M +$3M +15.4% Jan 1, 2013 Dec 31, 2013 10-K 2016-03-25
2012 -$19.5M Jan 1, 2012 Dec 31, 2012 10-K 2015-03-06
* An asterisk sign (*) next to the value indicates that the value is likely invalid.